Annual Cash & Cash Equivalents
$3.29 M
-$1.83 M-35.69%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual cash & cash equivalents is currently $3.29 million, with the most recent change of -$1.83 million (-35.69%) on 01 December 2023. During the last 3 years, it has risen by +$2.69 million (+442.89%). LIPO annual cash & cash equivalents is now -35.69% below its all-time high of $5.12 million, reached on 31 December 2022.LIPO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$1.35 M
+$167.20 K+14.09%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly cash and cash equivalents is currently $1.35 million, with the most recent change of +$167.20 thousand (+14.09%) on 01 September 2024. Over the past year, it has dropped by -$1.94 million (-58.90%). LIPO quarterly cash and cash equivalents is now -73.57% below its all-time high of $5.12 million, reached on 31 December 2022.LIPO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -58.9% |
| 3 y3 years | +442.9% | -4.3% |
| 5 y5 years | - | - |
LIPO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.7% | +442.9% | -73.6% | +1079.2% |
| 5 y | 5 years | -35.7% | +442.9% | -73.6% | +1079.2% |
| alltime | all time | -35.7% | +442.9% | -73.6% | +1079.2% |
Lipella Pharmaceuticals Common Stock Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.35 M(+14.1%) |
| June 2024 | - | $1.19 M(-43.6%) |
| Mar 2024 | - | $2.11 M(-36.1%) |
| Dec 2023 | $3.29 M(-35.7%) | $3.29 M(+36.7%) |
| Sept 2023 | - | $2.41 M(-22.6%) |
| June 2023 | - | $3.11 M(-22.5%) |
| Mar 2023 | - | $4.02 M(-21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.12 M(+262.3%) | $5.12 M(+4361.4%) |
| Sept 2022 | - | $114.80 K(-73.6%) |
| June 2022 | - | $435.00 K(+5.0%) |
| Mar 2022 | - | $414.40 K(-70.7%) |
| Dec 2021 | $1.41 M(+133.0%) | - |
| Dec 2021 | - | $1.41 M |
| Dec 2020 | $606.70 K | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly cash and cash equivalents year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual cash & cash equivalents?
The current annual cash & cash equivalents of LIPO is $3.29 M
What is the all time high annual cash & cash equivalents for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual cash & cash equivalents is $5.12 M
What is Lipella Pharmaceuticals Common Stock quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LIPO is $1.35 M
What is the all time high quarterly cash and cash equivalents for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly cash and cash equivalents is $5.12 M
What is Lipella Pharmaceuticals Common Stock quarterly cash and cash equivalents year-on-year change?
Over the past year, LIPO quarterly cash and cash equivalents has changed by -$1.94 M (-58.90%)